Navigation Links
Enova Medical Technologies Names Wayne Ramaker Vice President of Marketing and Communications
Date:10/29/2007

ST. PAUL, Minn., Oct. 29 /PRNewswire/ -- Enova Medical Technologies is pleased to announce today that Wayne Ramaker, an executive with nearly 25 years of market research and operations experience, has been named vice president of marketing and communications. The appointment is effective immediately. In addition to his new role at Enova, Ramaker will maintain his position as president of CJ Olson Market Research, Inc., an Enova affiliate based in Minneapolis, Minn.

Having been with CJO since 2004, Ramaker leads the company's executive team and oversees the areas of strategic planning, business development, and major account management. He also negotiated the merger with Enova in January of this year. Over the course of his career, Ramaker has held several management positions, including president and general manager of Homestore Plans and Publications, and director of operations at Damark International. Ramaker received his B.A. degree from Westmar University in 1982. He has been involved with several volunteer and professional organizations, including the National Consumer Software Products Council, Society of Consumer Affairs Professionals, and Habitat for Humanity.

"Wayne has excellent leadership qualities and tremendous experience that will help us market Enova's products and services to the medical community," said Fariborz Boor Boor, CEO of Enova. "In addition to his new role, Wayne will continue to be a liaison between Enova and CJ Olson Market Research, helping us to maximize the combined competencies of these two organizations."

Enova Medical Technologies, a privately-held company, is engaged in the development and commercialization of proprietary medical devices and is an experienced provider of product development, manufacturing, and commercialization services for the medical device industry. From Class I to Class III devices, Enova understands the technical challenges of product design, engineering, research and development, the regulatory steps required to successfully commercialize products, and the marketing and sales efforts needed to move inventory off the shelf. For more information, visit http://www.enovamedical.com.


'/>"/>
SOURCE Enova Medical Technologies
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Canadians Urged to Renovate Houses to Check Radon Gas Radiation
2. Check if your “Favourite medical web-site” is indulging in Quackey
3. Teens turning to Internet for medical queries
4. Robots craft medical history
5. NBE to conduct test for medical students from abroad
6. Air pollution combined with greater medical needs
7. Indian Nationals with Foreign Medical Degrees can now practice in India
8. Children! Protecting them from medical mistakes
9. More information sought by patients on medical errors
10. SARS necessitates medical masks
11. Meditation Works Medically
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete Coatings announced that ... rely on safety and cleanliness. This unique flooring system uses silver ion technology ... for centuries for its antimicrobial properties. Unlike antibiotics, which kill specific microorganisms, silver ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal Support Network’s annual essay ... kidney disease. The theme “Describe a positive decision that you have made about ... meet only one qualification— to have been diagnosed with chronic kidney disease. This ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer True ... edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes Convention ... speakers — representing such thought-leading companies as JP Morgan Chase, GE Digital, ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part ... company recently unveiled a redesigned website. The new site – still located at ... owners, architects, contractors and other industry users that Garland serves. , After an ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: